Fall Risk Assessment of Alzheimers Patient

Mrs. Janclet is a 75-year-old widow living in an assisted living facility for the aged. She has Alzheimers disease, and the facilities assisting nurse, Joleen, has brought her to Labgreen Hospital for the aged. Joleen helps the old lady walking enter the emergency room. The assisting nurse requests the attending medical physician to examine the old ladys risk of fall state. The old lady cannot clearly remember her history, and the accompanying personnel agrees to help on duty practitioner assess the patient. Patient falls are prevalent globally, especially for people above 65, and screening such individuals is necessary (Colmenero et al., 2021). The nurse answers questions about the old lady helps fill the Stay Independent brochure and assists the observing physician in carrying the various clinical tests on the patient.

The nurse helped to expound on the data collected from the Stay Independent brochure. Inquiry if the patient has fallen in the last six months indicated that she had fallen three times over the previous three months (Center for Disease Control and Prevention, 2021). The brochure and nurse revealed that they had advised the patient to walk on crutches within the assisting facility. The accompanying nurse indicated that the patient was always worried about falling while in the corridors of her residence. Joleen revealed an inquiry about her urinal incontinence and said that the patient frequently complained about urinal incontinence. The attending doctor asked the nurse if the Janclet complained of instability while walking, and Joleen reported that the patient regularly complained of feeling unsteady while walking. The nurse also insisted that the patient had a problem when stepping on the carb. An inquiry of the medications taken by the patient showed that Janclet was on antipsychotic and antidepressant medication. Najafpour et al. (2019) argue that using these medications in the elderly increases risk of falling. They obtained a score of nine from the Fall Risk brochure that was filled.

The thirty-second chair examination, four-stage balance test, and timed up and go test were conducted on the patient. They also measured the orthostatic pressure of the Janclet during the clinical examination. The thirty-second chair test is vital in assessing the strength of the lower muscles of an individual (Center for Disease Control and Prevention, 2021). Mrs. Janclet was just able to stand without using the armrest just four times in thirty seconds. With the support of the armrest, she only stood for six times, which shows a high risk of fall. The four-stage test examines the postural stability, and the patient could hold two positions for just three seconds and requested to sit. They subjected the patient to a timed and go test, proving a decreased step height, reduced stride length, and an abnormality in swinging arms. The pulse orthostatic pressure was measured and showed a drop in 25mmHg of blood pressure when changing from upright to supine. These clinical tests show that Mrs. Janclet is at considerable risk of falling and needs a close check.

Scientists associate osteoporosis with aging, as the bones become weak. The old also develop atherosclerosis, cardiac output decreases, and lungs show impaired gaseous exchange (Barrett & Barman, 2018). These factors all increase the chance of patient falls in the old. The degenerative changes that occur in joints intensify the risk of elderly falls. The United Kingdom recorded a 20% increase in mortality rates between 1990 to 2016 and a mortality rate of 2.4% in 2016 (Haagsma et al., 2016).

Diseases such as neuropathies, visual impairment, Parkinsons disease, osteoarthritis, and cardiovascular diseases predispose the patient to falls. Close monitoring of the patients by the adult care personnel would help reduce falls. Handrails on both sides of the staircases, bed alarms, gait belts, and fall prevention mats can help reduce falls. Education of the surrounding environment falls risk to elderly would help create awareness. Baris et al. (2016) estimated the cost spent on fall-related injuries was estimated to be US$3,302.60. Slade et al. (2017) state that the USA incurred US$31 billion due to fall-associated injuries. Other economic sectors would have benefitted if they had diverted these funds to them.

Alzheimers disease has affected the patients cognitive process and memory. A follow-up plan needs to be developed to help Mrs. Janclet, who is at significant risk of falling. Nurses need to build a better relationship with fall-risk patients to help prevent some cases of falls (Radecki et al., 2018). The physician advised that vitamin D supplementation should be given to help improve the patients postural stability. If the medications she is taking increase the number of falls, they should be stopped, and they bring the patient back to the health facility for a change in the treatment plan. Mrs. Janclet needs close monitoring, and they should train staff at assisted living centers to manage individuals at increased risk of falls.

References

Baris, V. K., Intepeler, S. S., & Yeginboy, E. Y. (2016). . Clinical Nursing Research, 27(2), 162179.

Center for Disease Control and Prevention. (2021).. Www.cdc.gov.

Colmenero, E., Gibson, J., & Hadley, L. (2021). .

Barrett, K. E., & Barman, S. M. (2018). Ganongs medical physiology examination & board review. Mcgraw-Hill Education.

Haagsma, J. A., Olij, B. F., Majdan, M., van Beeck, E. F., James, S., Vos, T., & Polinder, S. Falls in older aged adults in 22 European countries: incidence, mortality and burden of disease from 1990 to 2016. The Impact and Prevention of Fall-Related Injuries among Older Adults, 21. Web.

Najafpour, Z., Godarzi, Z., Arab, M., & Yaseri, M. (2019). International Journal of Health Policy and Management, 8(5), 300306.

Radecki, B., Reynolds, S., & Kara, A. (2018). Applied Nursing Research, 43, 114119.

Slade, S. C., Carey, D. L., Hill, A.-M., & Morris, M. E. (2017). . BMJ Open, 7(11), e017864.

Alzheimers Disease: Study Instruments

In the wake of increasing international concern on the prevalence of lifestyle conditions, researchers have shown relentless efforts to establish the causes and prevention of Alzheimers disease. This essay seeks to establish various factors that a researcher must consider during the selection of existing study instruments.

Factors Considered in the Selection of the Questionnaire Method as a Research Instrument

A researcher must ensure that the objectives of the study are clearly defined before the commencement of the research. Issues that pertain to the research must feature in the questionnaire. This strategy will ensure relevancy and preciseness (Sugiyono, 2008). The questionnaire ought to be simple and easy to read.

Another factor that should be considered is time availability. The instrument in question should not make the research cumbersome. Instead, it should ensure relevant information is captured in time. Adequate time for designing, piloting, monitoring, and evaluating of the instrument is an important aspect of selection.

Financial factors are crucial elements of a research instrument. Digital qualitative instruments that are mostly used in online researches are more expensive when compared to in-person methods. The plan is to operate within a manageable budget that does not escalate functional costs.

Lastly, most researchers ensure that the instruments of choice are reliable and valid. This situation maintains accurate and consistent results when such an instrument is used repeatedly in various studies.

Locating an Existing Questionnaire

Most researchers are able to locate exiting questionnaire through a review of existing literatures such as books, journals, and periodicals among others (Sugiyono, 2008). A researcher can also seek assistance from research experts who have conducted similar studies. They can facilitate the location of a relevant questionnaire for the prospective study (Sugiyono, 2008).

Search and Location of Questionnaire Instrument to be used

Effective research on the Alzheimers disease will involve location of the questionnaire using existing literatures on various studies that have been conducted to survey the malady. Examples of such literatures include a study that was conducted by Evans (1990) to estimate the prevalence of the Alzheimers disease in the USA. Information on the diagnosis and effects will be obtained from Cavanaugh and Blanchard-Fieldss (2002) research on the Alzheimers disease. These literature works will elaborate on demography, prevalence, and symptoms of the Alzheimers disease.

Level of Measurement of the Questionnaire to be used

The measurement of the questionnaire will be based on reliability and validity. The validity of the instrument will be measured using the Pearson Product Moment Correlation. On the other hand, its reliability will be measured using the Cronbachs Alpha technique (Cooper & Emory, 2002).

Type of Scale to be implemented for the Instrument

A five-point Likert scale whereby the awareness scores of the Alzheimers disease will be marked as 1 to represent highly aware of the disease, 2 for slightly aware of the disease, 3 for aware of the disease on average, and 4 for not aware of the disease (Sugiyono, 2008).

Data Collection Procedures to be implemented during the Study

To ensure that ethical standards are met, a pre-visit will be conducted to ensure familiarity with the area of study. Permission will also be requested from the relevant school and administrative authorities to ensure security (Sugiyono, 2008). Questionnaires will be distributed randomly to the various respondents in public places, hospitals, dispensaries, visiting caretakers at homes, and emailing the respondents who will have limited time for face-to-face conversations (Sugiyono, 2008).

Methodology

Extraneous Variables

The various extraneous variables that will affect the study include provision of wrong information by respondents concerning poor diets and better lifestyle among others. The variables will be controlled by creating a constant to measure the confounding factors.

Questionnaire Instrument

Questionnaires will be used for data collection. The structure of the questionnaire will comprise personal information of the respondent. It will also contain both closed and open-ended questions. Multiple-choice questions will also be included. The respondents will understand the questions easier since they will be written in simple English (Cooper & Emory, 2002).

Validity and Reliability

The Pearson Moment Correlation has been used to test for validity of the existing questionnaire. The instrument was rated above 0.5 marks. Thus, a 0.5 R-value was set as a mark for validity. The result was a 0.62 on average. This value was above the mark; hence, the instrument was valid (Cooper & Emory, 2002).

The reliability of the instrument was measured using the Cronbachs Alpha at 0.5. The positive correlation value-r and Cronbachs Alpha were above the 0.5 cut point. Therefore, the instrument was reliable. In summary, both the validity and reliability tests of the instrument were positive; hence, it was recommended for research (Cooper & Emory, 2002).

Table1: Information on Validity and Reliability test of the questionnaire

No. Variables Total correlation Cronbachs ± Illustration
Awareness of life style issues (x) 0.682 Reliable
Lack of exercise
Age
Poor diet
0.69
0.52
0.65
valid
Valid
Valid
Progress of Alzheimers disease (y) 0.644 Reliable

Plans for testing validity and reliability for testing a generate questionnaire

A pilot study will be carried out two months before the actual day of the study to ensure that validity and reliability of the generated questionnaire is tested and recommended for the study.

Interventions

Data collection procedures using the generated questionnaire

The questionnaires will be distributed to selected respondents by means of systematic random sampling technique. Two assistants who will simultaneously distribute the questionnaires to the respondents will accompany the researcher to save time. The questionnaires will then be collected from the respondents on the agreed day and time (Sugiyono, 2008).

Reference List

Cavanaugh, J., & Blanchard-Fields, F. (2011). Adult Development and Aging. Boston: Cengage Learning.

Cooper, D., & Emory, D. (2002). Business Research Methods. Chicago: Richard D. Irwin.

Evans, D. (1990). Estimated prevalence of Alzheimers disease in the United States. The Milbank Quarterly, 68(2), 267-289.

Sugiyono, J. (2008). Statistical for Research. Bandung, Indonesia: Alfabeta Press.

A Preliminary Care Coordination Plan: Alzheimers Disease

Introduction

Care coordination (CC) is an indispensable healthcare strategy providing the elaborated organization of patient care activities and information exchange among all stakeholders in inpatient treatment to deliver safe and productive care. Due to such plans, medical providers can ensure that the right people are familiar with the patients needs and preferences beforehand, allowing for reducing healthcare costs and staff errors. Therefore, this paper aims to develop a preliminary care coordination plan analyzing a health care problem, namely, Alzheimers disease, and related best practices to improve patients conditions. The plan will also establish goals addressing the chosen healthcare problem and identify available community resources for quality medical care.

Problem Examination

Problem Overview

Alzheimers disease (AD) is an irreversible, neurodegenerative disorder, the most prevalent form of dementia. Substantial deterioration in memory, especially short-term, and other cognitive skills, behavioral issues, and the conclusive impotence to conduct the simplest activities are the primary AD symptoms, mainly becoming noticeable at over 65 (Alzheimers Association, 2020). Specifically, as the disease progresses, symptoms can comprise language problems, disorientation in space and time, motivation loss, self-neglect, mood swings, and sudden fits of aggression, agitation, and anxiety. Currently, nearly 50 million people worldwide suffer from AD, and the number is expected to achieve over 130 million by 2050 (Liang et al., 2018). The overall estimated global cost of dementia accounts for above $800 billion (Liang et al., 2018). It is also worth noting that most incidents take place in low- and middle-income countries. Furthermore, some studies find that African Americans and Hispanics are at higher risk for AD (Alzheimers Association, 2020). A recent study indicated that the disease is more predominant in women than in men (Liang et al., 2018). Altogether, AD places a significant physical, psychological, and social burden on both people with AD and their families and caregivers.

Causes and Pathophysiology

Scientists presently have a poor understanding of the causes and development of Alzheimers disease. The disorder is assumed to occur when excessive amounts of proteins, particularly beta-amyloid and tau proteins, congest the brain and penetrate the cells (Alzheimers Association, 2020). Plaques of beta-amyloid, known as oligomers, can cause neurons damage and death by disrupting communication between neurons at synapses. Simultaneously, tau tangles obstruct nutrient transportation, especially glucose, and other vital substances inside neurons. Such processes are always accompanied by inflammation and atrophy, principally produced by the activated immune system that clears the brain from dead and dying cells (Alzheimers Association, 2020). The prime root of these protein dysfunctions is obscure and requires further in-depth research. Therefore, to explain ADs possible causes, the main proposed hypotheses include the amyloid hypothesis, tau hypothesis, genetic, and infectious hypothesis.

Best Interventions

Many methods have been offered to prevent and treat AD, but their impact on the diseases course and its severity is not considerable or poorly determined. Concerning disease prevention, physicians can recommend a balanced diet that contains fruits and vegetables, bread, wheat, and other cereals, olive oil, red wine, and healthy seafood. Physical activity (PA), primarily aerobic exercise, is also related to a decreased risk of AD and its severity. Additionally, intellectual activities such as board games, reading, learning a new language, playing musical instruments, doing crosswords, and active, stimulating communication may postpone the onset of the disease or slow its progression.

Furthermore, doctors can propose pharmacologic and non-pharmacologic therapies to improve patients physical and mental status. The US Food and Drug Administration (FDA) approved five medicines for curing AD, including donepezil, rivastigmine, memantine, galantamine, and memantine with donepezil (Alzheimers Association, 2020). Except for memantine, these medications can temporarily enhance cognitive signs by increasing the brains neurotransmitters. The drugs effectiveness considerably depends on patients organism and is limited in duration.

Beneficial psychosocial intervention can comprise the combination of aerobic and non-aerobic exercises, music therapy, and computerized cognitive training (CCT). For example, the meta-analysis by Liang et al. (2018) concluded that PA and CCT demonstrated noticeable improvement in conditions of individuals with AD. Additionally, transcranial magnetic stimulation (TMS) displays notable effectiveness concerning AD. Specifically, a recent systematic review by Limori et al. (2019) confirms the favorable cognitive impact of TMS on patients. The studies also assume that nonpharmacological treatments may be more useful than pharmacological therapies.

Goals to Address the Problem

Although the ultimate treatment of AD is absent, healthcare providers should strive for specific objectives that can deliver relief from the disorders course. Firstly, all persons, irrespective of their social, racial, or gender status, should have access to quality healthcare services and be cared for equally. The second goal primarily concerns nurses who should comply with hygiene rules, including washing and disinfecting exposed parts of the body and wearing gloves and masks. The third objective is to help patients with AD perform their daily tasks and doctors recommendations and prescriptions, especially taking pills, walking outside, dressing up, or going to the toilet. The final goal is that nurses should provide relevant and accurate information and long-term, broad cooperation with family members or caregivers, which better patient wellbeing.

Community Resources of Minnesota

The state of Minnesota possesses a sufficient amount of community resources to deliver safe and adequate care for people with AD. As of 2020, about 99000 patients suffering from Alzheimers disease in Minnesota, and, by 2025, this number will increase to 120000, that is, 21 percent, according to Alzheimers Association (2020). Total Medicaid payments for older Americans with AD or other dementias account for $905 million (Alzheimers Association, 2020). In addition, the numbers of caregivers of individuals with AD in Minnesota comprise 257000. Mayo Clinic is a non-profit organization, one of the largest private medical and research centers globally, specializing in holistic healthcare, research, and education. Currently, the entity serves 1.2 million people and employs almost 7000 medical consultants, about 4200 research personnel, and over 63000 administrative and allied health staff (Mayo Clinic Facts, 2019). Furthermore, Mayo Clinic offers high-quality digital healthcare service that provides video appointments, access to personal healthcare records and medical information, remote patient monitoring, and around-the-clock communication with doctors and care staff.

It is worth noting that the clinic provides comprehensive and up-to-date medical approaches that enhance the conditions of patients with AD and conducts research in the Neurology and Psychiatry and Psychology departments. Mayo Clinic in Rochester has nine available doctors, including Bradley Boeve, M.D., Ulas Camsari, M.D., Daniel Drubach, MD, and others (Mayo Clinic Staff, 2020). There are other organizations in Rochester, including Alzheimers Association Caregiver Support Groups (Location: 435 E. Henrietta Road Rochester, NY 14620) or Support Group for Individuals with Dementia (Location: Alzheimers Association Office, 435 E. Henrietta Road, Rochester). Overall, the resources provide financial and moral support, training, and communication with persons with AD, which favorably impact a safe and effective continuum of care.

In conclusion, the paper had provided a preliminary care coordination plan analyzing AD and related best practices to improve patients conditions. In particular, Alzheimers disease is an irreversible, neurodegenerative disorder characterized by a significant deterioration in memory, mainly short-term, and other cognitive abilities in people aged over 65. Although treatment for this disease is not available, doctors can recommend different useful health improvement methods, such as aerobic exercises, music therapy, CCT, TMS, and drugs, namely, donepezil, rivastigmine, memantine, and galantamine. The principle goals to address this problem include broad access of the population to healthcare services, early diagnosis, ascertaining and treating complementary physical or psychological illnesses, and selecting comprehensive treatment.

References

Alzheimers Association. (2020). 2020 Alzheimers disease facts and figures. Alzheimers & Dementia, 16(3), 391460.

Liang, J.-H., Xu, Y., Lin, L., Jia, R.-X., Zhang, H.-B., & Hang, L. (2018). Comparison of multiple interventions for older adults with Alzheimers disease or mild cognitive impairment: A PRISMA-compliant network meta-analysis. Medicine (Baltimore), 97(20), e10744.

Limori, T., Nakajima, S., Miyazaki, T., Tarumi, R., Ogyu, K., Wada, M., Tsugawa, S., Masuda, F., Daskalakis, Z. J., Blumberger, D. M., Mimura, M. & Noda, Y. (2019). Effectiveness of the prefrontal repetitive transcranial magnetic stimulation on cognitive profiles in depression, schizophrenia, and Alzheimers disease: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 88, 3140.

Mayo Clinic facts. (2019). Mayo Clinic.

Mayo Clinic Staff. (2020). Departments and specialties. Mayo Clinic.

Care Services for Patients with Alzheimers Disease

Alzheimers disease is common among elders aged 65 and older and is a neurological disorder affecting brain cells. Alzheimers disease is one of the most common diseases among nursing home residents in the United States. According to data provided by the Joint Commission, in 2021, more than six million Americans lived with Alzheimers dementia in the United States (2022). The growing number of Alzheimers cases requires the addition of new updated requirements to nursing care centers.

Firstly, licensed nursing care homes may establish separate special care units for patients with Alzheimers disease to increase the quality of care and provide a more appropriate environment suitable for patients needs. Standard nursing homes are subjected to accreditation programs and requirements established by Alzheimers Association. The new standards recommended by The Joint Commission suggest establishing staff training and orientation centered on improving cognitive screening and the ability to recognize dementia symptoms and prioritizing individualized care for patients. Nursing homes with separate Alzheimers disease units are subjected to more strict standards, including a minimum ratio of nursing care per resident and staffs extended in-service training on Alzheimers disease.

Standard in-home care implies patients stay at their own houses with the goal of providing assistance to the caregiver. In-home services include a wide range of service types for patients with Alzheimer depending on their needs. There are no specific requirements for in-home care providers; therefore, it is necessary for caregivers to ensure that they are qualified to care for patients with Alzheimers disease. Furthermore, consumer-directed care prioritizes patients input into the treatment process through a partnership approach. Consumer-directed care utilizes new organizational mechanisms where patients have more control over care services and choose the ways in which care services will be provided to them.

Furthermore, the PACE (Program of all-Inclusive Care for Elderly) model is a relatively new care system successfully implemented for patients with Alzheimers disease with a goal of preventing nursing home admissions. The program provides an opportunity for patients with Alzheimers dementia to stay independent without losing the benefits of care services. The program can include a wide range of services, from in-home assistance and home health care to meal delivery. Compared to consumer-directed care, the PACE model allows patients to independently live in their own homes or with informal caregivers. The care model is implemented across a team or organization, meaning that the program requires the participation of healthcare and management professionals. On the other hand, unbundling of care services delivery stands for the process when healthcare providers separate services and procedures even though they were performed together. The PACE model favors the unbundling of care services to ensure that more uninsured patients can afford care services.

Thus, analyzing the differences between standard methods and new organizational arrangements for care in patients with Alzheimers dementia provided a substantial insight into understanding which care methods are more effective and identifying possible improvements. Firstly, the new approach in consumer-directed care, which prioritizes the input of patients with Alzheimers disease in care, can improve the caregiving results by empowering patients and caregivers. Next, the PACE model provides a significant opportunity for patients with dementia to maintain their independence without experiencing significant changes in their daily routine. Considering the growing number of patients with Alzheimers disease, further improvements should focus on assisting and maintaining patients independency to avoid overflow in nursing homes with special care units for patients with Alzheimers disease. Furthermore, broad implementation of the PACE model in combination with unbundled service delivery can make care services more affordable for uninsured patients with Alzheimers dementia.

Reference

The Joint Commission. (2022). The Alzheimers Association and The Joint Commission collaborate to improve quality and safety in dementia care. Web.

Alzheimers Disease and Dementia

Dementia is considered a general term for impairments in mostly remembering, moving, and thinking that serve as obstacles in a persons everyday activity. However, the term is also strongly associated with the following problems: reasoning, problem-solving, attention, and communication. Furthermore, dementia is extended to numerous diseases with the most accurately identified symptoms. Overall, dementia outcomes stem from its negative influence on the body parts responsible for the damaged functions.

To begin with, the disease tends typically to affect older adults; however, it is not necessary identified in every more senior person. The rates of people with impairments are expected to soar in the following 40 years considerably, but today, there is an estimated 5.0 million adults with dementia (Centers for Disease Control and Prevention, 2019, para. 2). Furthermore, people are more likely to suffer from dementia due to their family history. An individuals race is also crucial when estimating ones chances of developing dementia, Hispanics 1.5 times more likely to have dementia than whites (Centers for Disease Control and Prevention, 2019, para. 12). In addition, negative habits like smoking might also play a pivotal role in provoking the disease as well as constant head injuries that affect the brain operations (Centers for Disease Control and Prevention, 2019). As a result, any type of this disease yields disadvantageous repercussions to the brain and, consequently, the human body on the whole.

As stated, every type of dementia is generally characterized by its impairment symptoms. For instance, Alzheimers disease is widely recognized by the problems with memory and walking that follow the development of this disease. In addition, it is considered one of the most common dementia types as it accounts for 60 to 80 percent of cases (Centers for Disease Control and Prevention, 2019, para. 24; Mahendra et al., 2018). Vascular dementia, on the contrary, is stronger associated with blood flow issues and is characterized by its step-wise fashion, meaning symptoms will suddenly get worse as one gets more strokes (Centers for Disease Control and Prevention, 2019, para. 25). However, dementia can also include problems with movement and balance, the same as the Lewy Body type of this disease (Centers for Disease Control and Prevention, 2019). To be more exact, this common type of dementia is also followed by changes in alertness including daytime sleepiness, confusion, or staring spells (Centers for Disease Control and Prevention, 2019, para. 25). Another critical point is that if an individual experiences numerous impairments in ones brain functions, then it is possible for a person to experience mixed dementia, the combination of disease types.

Still, this condition might also negatively affect the behavioral aspect of a persons brain and sometimes communication skills. Fronto-temporal dementia is also common among older adults as it is identified in more than 5% of the cases (Centers for Disease Control and Prevention, 2019). This type of disease is usually caused by the changes in the brain that provoke negative alternations in the behavior of an individual (Centers for Disease Control and Prevention, 2019). In other words, people who experience fronto-temporal dementia tend to behave ridiculously and sometimes embarrassing. Overall, the most common types of this disease are Alzheimers, vascular, and lewy body one.

Another critical point is that abnormal changes in the human brain cause any type of dementia. Consequently, the stated alternations trigger the decrease in a persons skills and senses crucial for maintaining a comfortable everyday life (Alzheimers Association, 2021). Therefore, due to the persons ethnicity or family history, one might experience the development of the disease and, consequently, its influence on ones brain operation. Dementia yields numerous negative consequences to the human brain, such as decreasing numbers of neurons, destroying their networks (U.S. Department of Health and Human Services, 2021). Consequently, neurons weakening leads to the disruption of other processes related to the impairment of a specific disease type (U.S. Department of Health and Human Services, 2021). In addition, the negative influence on various areas of the brain develops into a decrease in social behavior. In other words, dementia usually is characterized by its ability to damage not one part of the human brain but others, not necessarily related to each other.

Furthermore, the person starts experiencing impairments in numerous functions due to the brain areas being damaged. As a result, because of such a harsh influence on an individual, one might lose the ability to live and function independently (U.S. Department of Health and Human Services, 2021, para. 14). Overall, dementia leads to the persons death since one can no longer function along with problems in different functions necessary for everyday life.

To sum up, numerous types of dementia are widely identified by the kind of impaired functions. Furthermore, the influence of the disease is frequently fatal to an individual as one starts experiencing a decrease in numerous brain areas leading to the inability to live independently. In other words, dementia damages innumerable parts of the human brain, worsening a persons skills, such as thinking, mowing, communicating, and remembering.

References

Alzheimers Association. (2021). What is dementia? Alzheimers Disease and Dementia. Web.

Centers for Disease Control and Prevention. (2019). What is dementia? CDC. Web.

Mahendra, N., Bourgeois, M. S., & Hickey, E. M. (2018). Cognitive-communicative characteristics: Profiling types of dementia. Semantic Scholar. Published. Web.

U.S. Department of Health and Human Services. (2021). What happens to the brain in Alzheimers disease? National Institute on Aging. Web.

Preparing a Podcast on Dementia and Alzheimer

The rationale for the chosen topic and why this is a public health issue

Alzheimers disease (AD) and dementia is the podcasts topic. Where the objective is to inform the aged group, which is the target group, about the disease. The explanation is given to describe fully what dementia and Alzheimers are, their causes, and preventive measures. AD is an impairment of an intellectual function of a person persistently where there is the development of difficulty in memory and language. There is an alteration in ones ability to identify the relationship between visual and spatial objects and mental skills, including working memory, flexible thinking, and self-control, as there is a change in cognitive skills when the disease develops (Abdelhamid, 2018). Finally, memory loss of memory, disorientation, and aphasia is manifested. The patients develop cortical dysfunction and may, at last, be immobile, mute, and disabled. The above effects make the disease a public health issue that should be addressed by both the patients of AD and their caregivers.

Dementia and Alzheimers disease are feared so much by older people that it is commonly associated with the aging population. The danger of the disease is seen in its irreversible and progressive nature after infecting the brain. This, in return, affects thinking skills robbing the infected of their personality and independence since they cannot be alone but somewhat under close care to avoid messing up (Alzate, 2018). Indeed, it is not a normal part of the aging process, but it is more common as people get older since in every person 71 and older, roughly 14%of the population has dementia (Beam et al., 2018). The national statistics indicate that the population of those aged 65 years and above in the USA is expected to double from approximately 35 million today to more than 70 million by 2030, making the need for education on the condition a very acute community health need (Beam et al., 2018). Since nothing stops the process of aging except death, treating the catalyst to a disease like depression is of great significance, for Alzheimers is not curable. Beam (2018) shows that the death rate from dementia and Alzheimers is high in the local areas where quality health has not been attained. In addition, there is little knowledge about AD in the local villages compared to the urban areas. Nationally developed countries are better placed in preventing the disease as compared to the developing countries where health facilities are not well equipped with equipment as well as the research about it. Globally AD remains an alarm due to the increase in the number of people who die of it; hence a lot of research is being done to eradicate fully eradicate the disease (Bowden, 2017).

The target group

The target group for this podcast is older adults who are often affected by this dangerous disease. Only 34.8 percent of adults aged 65 or over with a dementia diagnosis were aware of the dementia diagnosis in 200709. Hence, this podcast will help create awareness that though dangerous, the disease can be handled with care to slow its infection rate (Berchtold et al., 2018). Increasing age is most identifiable in cases of dementia; after age 65, the prevalence and the incidences of dementia double approximately every 56 years (Berti et al., 2018). Using the area surveys and reports of the census, this group will be identified and educated on the preventive measure of the disease and educate the caregivers on how to handle those already infected.

Mental Health Problems associated with dementia are highly rated for those with depression, personality disorders, and psychotic conditions. These problems might be in up to 50% of older adults with Alzheimers disease (Bharadwaj et al., 2016). Community awareness and education, as well as public outreach, would bring clear information about health care providers, long-term care, home, and community-based services, insurance coverage, financial assistance and planning, legal protections, family communication, caregiving, roles and tasks, caregiver coping, respite, day-to-day symptom management, and self-care (Bowden, 2017). The podcast will address isolation and inactivity. There is a close correlation between loneliness and dementia development, though not a vital cause of the malady (Cantón Habas et al., 2019). There is a significant barrier to social life for people with dementia; hence the information contained here will help handle the patients (Berchtold et al., 2018). Many conclude that their local communities have given up on them and do not offer any support, which puts them alone, increasing anxiety and fear.

The fact that older adults have outlived their family members and friends makes them older orphans who contribute nothing to society, leading to depression and other mental health maladies (Yousaf et al., 2020). This has affected them socially since they are limited to enjoying the privileges they could enjoy while in good health, such as socialization (Cantón Habas et al., 2019). Continued evaluation of services should be done to maintain their effectiveness. When patient-centered measures are developed, there will be affordable, quality healthcare for older adults.

The key messages and evidence

The key messages in the podcast include the nutritional causes of Alzheimers disease and the recommended diet to prevent it. The exact causes of AD are still unknown to scientists (Ton, 2020). AD is commonly associated with type II diabetes, weight loss and weight gain, smoking, alcohol, lack of a nutritious diet, inadequate physical activity, lack of social engagement, and lack of mentally stimulating activities (Chai et al., 2019). Nutrition is a critical factor behind the causes of AD, and research done by Dr. de La Monte (2018) brought the connection between dietary deficits and the development of AD. High carbohydrate consumption and sugars and a fat and protein diet trigger AD (Alzate, 2018). Poor blood sugar management also accelerates Alzheimers disease, referred to as Type 3 Diabetes (Dafsari and Jessen, 2020). According to Zimmerman (2019), a quarter of all dementias result from nutritional factors that are partially reversible. High cholesterol levels from a high intake of saturated fats and trans-unsaturated fats also cause the disease.

The dietary recommendations in the podcast to prevent AD include the intake of fruits, vegetables, lean meats, omega three foods such as salmon, whole grains, and low-fat dairy products. Increased fresh foods and decreased processed foods also prevent AD (Fisher and Hanin, 2018). Soy, which heals heart diseases, contradicts AD, leading to memory problems. The best diet to be considered is the Mediterranean diet which has a low risk of developing AD (Abdelhamid, 2018). The diet recommendation is a high intake of unsaturated fatty acids, moderate to high fish intake, low meat and poultry intake, and moderate amounts of red wine (Olmastroni et al., 2020). In dietary supplementation, 400 mcg per day of folate and folate-rich foods such as orange juice, cooked spinach, and asparagus are recommended to prevent AD.

The considerations that underpin the format and content of the podcast

The aged group will easily follow the podcast if the language is supportive and engaging. This would make them realize that society is an essential group that plays a crucial role. In addition to that, the podcast also represents the aspect of a health promotion tool, an essential aspect of conveying health communication to older adults (Bharadwaj et al., 2016). The preventive measures to mitigate AD are in the podcast, which should be followed keenly to reduce its infection rate. These recommendations include screening for malnutrition, monitoring body weight, oral nutrition in combination with attractive food delivered in a pleasant environment, and supplementation of nutrients only if there is a deficiency (Ouanes and Popp, 2019). When a crisis requires artificial nutrition, the nutritional intake is done due to a reversible condition. However, it should be noted that artificial treatment is not appropriate for those patients reaching the end of life phase of their disease.

The cross-cutting issues

One key issue cutting across is that Alzheimers and associated dementias are incurable and irreversible. As a result, the drugs administered only slow the development with time. Unfortunately, the disease begins gradually; hence it is necessary to maintain frequent testing of the aged group (Sundström, 2019). Research shows that no matter how the disease is prevented by observing the required diet, it can never be cured, and eventually, the patient dies (Ouanes and Popp, 2019). Another evident issue is that nutrition in terms of proper diet will help prevent AD. If the diet is followed correctly, the patient can live longer since the diet has the nutrients that boost brain cells. A person with dementia who feeds on a fatty diet is likely to die after a short period.

The podcast promotion

Developing a professional communication plan will attract more audiences. Explaining to them how dementia has become a threat to many people will automatically make them interested in having the podcast for more information. Since negative comments are inevitable in the podcast, I will, first of all, not take them personally but rather address them using the facts I have about the topic of study, hence winning the minds of those who comment negatively. I will then use the audience in promoting the podcast since there is a huge crowd to listen to what is contained in the podcast. Research shows that social media helps to encourage more listeners, particularly for promoting health information, because a vast audience was gathered after posting on social media (Balls-Barry et al., 2018). Many people will learn more about AD and dementia, becoming educated on handling patients suffering from it. Any question about the topic will be appropriately answered since different people have different questions depending on their experience with such patients (Scholefield, 2019). Weekly or daily updates on the subject can also promote the podcast by keeping the social media updated on every detail about the AD. The podcast will be a classroom that will provide a guideline to both the infected and the affected audience. Information like the statistics of people under medication will motivate those in fear and anxiety in nursing patients with AD.

A brief reflection on the finished podcast

The finished podcast has helped me have great knowledge about dementia and Alzheimers. It helped the caregivers get informed on how to mitigate the disease. I have learned the causes of the diseases and the target group prone to suffer from them. Preventive and control measures have also been covered in the podcast, conveying knowledge to everyone. From the time one suffers from it, I could not imagine that one could have lived for twenty years after following the prescribed measures in the podcast. Due to its importance, I would wish that the next time the podcast could be published, it would restore many lives of those who thought that Alzheimers was the end of life. Next time we could consider adding more professional aspects to the podcast and covering several emerging health issues. Some health promotion podcasts are fundamentally different as they include a jingle. Including information about the supportive organization would help save the lives of those who cannot afford the cost of treatment and maintain the proper diet.

Reference List

Abdelhamid A. et al. (2018) Effectiveness of interventions to directly support food and drink intake in people with dementia: systematic review and meta-analysis, BMC geriatrics, 16(26).

Alzate, L. (2018) Alzheimers disease. Nutritional perspectives, Journal of the Council on Nutrition, 41(2), pp. 2835.

Beam, C.R et al. (2018) Differences between women and men in incidence rates of Dementia and Alzheimers disease, Journal of Alzheimers Disease, 64(4), pp. 1077-1083.

Berchtold, N.C. and Cotman, C.W. (2018) Evolution in the conceptualization of dementia and Alzheimers disease: Greco-Roman period to the 1960s, Neurobiology of Aging, 19(3), pp. 173-189.

Berti V. et al. (2018) Mediterranean diet and 3-year Alzheimers brain biomarker changes in middle-aged adults, Neurology, 90 (20).

Berti V. et al. (2018) Nutrient patterns and brain biomarkers of Alzheimers disease in cognitively normal individuals, Journal of Nutrition, Health & Aging, 19(4), 413423

Bharadwaj S. et al. (2018) Malnutrition: laboratory markers vs. nutritional assessment, Gastroenterology report, 4(4), 272280.

Bowden, J. (2017) Defeating Alzheimers, Better Nutrition.

Cantón Habas et al. (2020) Depression is a risk factor for dementia and Alzheimers disease, Biomedicines, 8(11), p.457.

Chai B et al. (2019) Vitamin D deficiency as a risk factor for Dementia and Alzheimers disease: an updated meta-analysis, BMC Neurology, 19(1), pp.1-11.

Dafsari, F.S. and Jessen, F. (2020) Depressionan underrecognized target for prevention of Dementia in Alzheimers disease, Translational Psychiatry, 10(1), pp.1-13.

Fisher, A. and Hanin, I. (2018) Potential animal models for senile Dementia of Alzheimers type, with emphasis on AF64A-induced cholinotoxicity, Annual Review of Pharmacology and Toxicology, 26(1), 161-181.

Olmastroni E. et al. (2021) Stating use and risk of Dementia or Alzheimers disease: a systematic review and meta-analysis of observational studies, European Journal of Preventive Cardiology.

Juanes, S. and Popp, J., (2019) High cortisol and the risk of Dementia and Alzheimers disease: a review of the literature, Frontiers in Aging Neuroscience, 11(5), p. 43.

Scholefield M. et al. (2021) Widespread decreases in cerebral copper are expected in Parkinsons disease dementia and Alzheimers disease dementia, Frontiers in Aging Neuroscience, 13, p. 81.

Sundström et al. (2020) Loneliness increases the risk of all-cause dementia and Alzheimers disease, The Journals of Gerontology: Series B, 75(5), pp. 919-926.

Ton A. et al. (2020) Oxidative stress and dementia in Alzheimers patients: effects of synbiotic supplementation, Oxidative Medicine and Cellular Longevity, 2020.

Yousaf K. et al. (2020) A comprehensive study of mobile-health-based assistive technology for Dementia and Alzheimers disease (AD) healthcare, Health Care Management Science, 23(2), 287-309.

Single Children Caregivers vs. Married Couple Caregivers: Alzheimers Disease

Introduction

The purpose of this topic is to expand research on Dementia/Alzheimers Disease from the standpoint of the caregiver perspective. The disease was named after Dr. Alois Alzheimer, a doctor and an academic, who wrote his first paper on clinical dementia. His first study was on a woman by the name of Ms. Frau Auguste. Dr. Alzheimer had been the patient for 5 years until she died in 1905 from the chronic illness known as Dementia/Alzheimers (Kennard, 2006).

Because of the support that married couple caregivers have, the instances of Alzheimers disease in the latter are comparatively easier to address.

Literature review

Table 1. Literature used for the research

Author(s) Date Fieldwork approach Description of the method Findings
Freida Jean Fuller 1992 Qualitative 52 men were interviewed regarding the change in their family roles after their wives developed AD. Fuller stresses the benefits for a caregiver to work with Alzheimers disease-affected patients, who have families and, preferably, spouses, since Spouses are known to provide substantial and consistent care (Fuller, 1992, p. 2). More to the point, Fuller acknowledges that age is often a considerable restriction in self-care.
Melva Jean Hayes 2003 Qualitative Several focus groups were interviewed on the change of relationships with their AD partners. People with dementia demonstrate impressive progress when there is a loving spouse by his/her side since it allows them to retain their integrity, self-esteem, and social role. The problems regarding the intimate aspect of family life, however, may pose a threat to the spouses relationships (Hayes, 2003).
Jian Li 2006 Mixed (qualitative and quantitative) Seven well-validated instruments were used to create 5 questionnaires for caretakers of people with AD. The treatment of AD patients is much more efficient in families since the physician has access to the familys medical records and is capable of defining the key hereditary factors that may have caused Alzheimers (Li, 2006).
Mary E. ODonnell 1997 Qualitative Phenomenological research was used Though ODonnell admits the benefits of family caregivers (ODonnell, 1997), the researcher claims that there are practically no differences between the strategies for addressing Alzheimers disease both in people with and without families.
Tracy Davis Yaeger 1990 Qualitative 4 types of questionnaires were distributed among the participants (caregivers for spouses with AD). After a comparison of the family relationships between people with Alzheimers and their relatives for the patients who attended daycare and those who preferred to be treated at home, it was revealed that the condition of the former deteriorates due to numerous family conflicts, whereas those staying at home reported improvement in communication with family members since the latter to have the support of family members to integrate back into the society successfully (Yaeger, 1990).

Analysis

The term Alzheimer/ dementia is traditionally used as an umbrella term for symptoms of cognitive decline, including sclerosis, yet it is not considered a clinical diagnosis until an underlying disorder has been defined (Psych Central, 2014). Dementia is also applied to the symptoms that have been triggered by brain function alterations. The symptoms of the given disease include, but are not restricted to, reiterating the same question; loss of spatial orientation skills; inability to follow basic directions; losing the track of time, forgetting peoples names; complete disregard of ones safety, hygiene, or nutrition. The pace of dementia progress varies depending on the patients health issues (National Institute on Aging, 2014).

Conclusion

Because of different rates in the loss of caregivers abilities, parents affected with Alzheimers must have someone by their side, whose behavioral and communicational patterns they can follow. Thus, Alzheimers treatment is more efficient in married couples.

Reference List

Fuller, F. J. (1992). Health of elderly male dependent-care agents for a spouse with Alzheimers disease. Ann Arbor, MI: ProQuest.

Hayes, M. J. (2003). Negotiating and managing intimacy when the gendered self is threatened: Living and loving with Alzheimers disease. Ann Arbor, MI: ProQuest.

Kennard, C. (2006). Did Dr. Alzheimer discover Alzheimers disease?

Li, J. (2006). Effects of psychological stress and cytokine genes on humoral immune response to tetanus toxoid adsorbed in family caregivers of Alzheimers disease patients. . Ann Arbor, MI: ProQuest.

ODonnell, M. E. (1997). The lived experience of uncertainty for spouse caregivers of people with Alzheimers disease. Ann Arbor, MI: ProQuest.

National Institute on Aging (2014). Alzheimers Disease Education and Referral Center.

Psych Central (2014). Learn. Share. Grow. What is dementia? Web.

Yaeger, T. D. (1990). Factors influencing family caregivers utilization of adult day care for persons with Alzheimers disease. Ann Arbor, MI: ProQuest.

Dementia of Alzheimers Type: Signs and Symptoms

Abstract

The world today is faced with many diseases and conditions, some of which have given medical researchers sleepless nights. Among the complicated diseases is Alzheimers disease, which is a complication in the brain that leads to memory loss. This paper seeks to analyze dementia that comes about as a result of Alzheimers disease. The signs and symptoms of the disease will also be discussed, as well as its stages. Despite spending sleepless nights researching, researchers have not yet come up with a cure for Alzheimers disease, and therefore its management is a crucial intervention for patients. Later in the paper, management by caregiving will also be looked at by discussing the role of the family in taking care of patients with Alzheimers disease.

Introduction

Alzheimers disease, commonly abbreviated as AD, is a condition that affects the human brain leading to memory loss and impairment of major mental functions. AD comes about after the disintegration of brain cells connection thus causing the mental function and memory to decline steadily (Wayne et al., 2013, p.1). Research done on AD indicates that it has no cure hence management is the sole way of mitigating the effects of the disease. Alzheimers disease is known to occur in aged people, particularly those who are over 65 years. The prevalence of Alzheimers disease, therefore, increases with age, thus about fifty percent of the population of people above 65 years suffer from AD. However, it is important to note that not all aged people suffer from AD. If not well managed, Alzheimers disease leads to dementia, which is a group of brain disorders that result in the loss of intellectual and social skills (Wayne et al., 2013, p.1). This paper is therefore an in-depth analysis of dementia that is caused by AD.

Signs of Alzheimers disease

The early signs of AD can be confused with age-related disorders or stress disorders. Alzheimers disease is known to manifest itself differently in different people. Nevertheless, common signs and symptoms of the disease include the following:

  1. Lack of ability to remember events
  2. Mood swings
  3. Irritability
  4. Confusion
  5. Aggression
  6. Language problems
  7. Memory lapses
  8. Withdrawal
  9. Loss of bodily functions
  10. Poor thinking ability

Stages of Alzheimers disease

Alzheimers disease is known to occur in seven key steps, which give an indication of how the human brain changes within the course of disease manifestation.

  • Stage 1: No impairment

During this stage, the individual will function normally without showing any signs of memory loss or dementia.

  • Stage 2: Very mild decline in cognition

In this stage, memory lapses start being experienced. An individual easily forgets common and familiar words, places, or names. Nevertheless, no symptoms of dementia are detected.

  • Stage 3: Mild decline in cognition

Here the people close to the affected individual begin noticing the patients memory problems. This is evidenced in their character or behavior. Patients may have problems remembering peoples names upon introduction, trouble with planning, misplacing important objects, and having trouble performing routine tasks (Jalbert et al., 2008, p. 16).

  • Stage 4: Moderate decline in cognition

During this stage, the symptoms of dementia are recognizable and can be easily detected upon medical examination. Patients will forget recent activities and occurrences when in this stage. In worse cases, the patient may not be able to plan for events as well as become very moody and withdrawn.

  • Stage 5: Moderate severe decline in cognition

In this stage, memory lapses are highly noticeable whereby the patients require help in the common day-to-day errands they earlier performed without difficulties. For instance, individuals may not be able to even remember their home addresses or mobile numbers. Arithmetic computations become extremely difficult during this stage. However, the patient is still able to perform the core duties of eating and going to the washrooms.

  • Stage 6: Severe decline in cognition

This is the middle stage of AD, which is characterized by severe memory lapses that make the individual completely forgetful. It is so serious that at times patients forget their own names and have difficulty distinguishing faces that were very familiar to them. There is also a significant change in the sleeping pattern whereby patients tend to spend the day sleeping hence becoming restless during the night. Patients also have problems in controlling their bowels and may need help in routine toileting such as flushing or disposal of waste.

  • Stage 7: Very severe decline in cognition

This is the last and the most serious stage of AD. At this stage victims become uncontrollable and they may fail to recognize their environments. Speech becomes impaired with patients requiring help in most of the personal care activities such as toileting and eating. In severe cases, muscles may become rigid thus resisting movement because of abnormal reflexes.

Risk factors of Alzheimers disease

The exact causative factors for AD have not been established but there are claims indicating that the disease could be brought about by the inheritance of some genes. However, these will be manifested shortly before the age of 65. Researchers claim that AD comes about due to a set of complex factors occurring in the brain. Therefore, the common risk factors of AD include age whereby it occurs in old age especially after 65 years, gender whereby women are more prone to AD than men, and family history. People with head injuries are also at risk of suffering from AD as well as exposure to some environmental toxins (Jalbert et al., 2008, p. 19). Other risk factors include stroke, heart disease, high blood pressure, and high levels of cholesterols among others (Jalbert et al., 2008, p. 19).

Diagnostic criteria / nursing assessments

Unlike most medical conditions that can be diagnosed using lab tests, the diagnosis of Alzheimers disease is quite involving. Diagnosis is achieved by looking at the patients history, relatives history and observing the patient clinically. To diagnose Alzheimers disease, the past and present functioning of the patient ought to be determined for any instances of disorientation. This could include background checks on family history, memory loss and other medical tests. This will also help in distinguishing AD from other types of dementia.

Interventions (pharmacological and non-pharmacological)

It is important to note that there is no cure for Alzheimers disease. However, the disease can be successfully managed to give a patient a normal life. Under pharmacological interventions, the common medications used are acetyl cholinesterase inhibitors such as galantamine, tacrine, donepezil, memantine, and rivastigmine (Becker and Giacobini, 1997, p. 102). Nevertheless, these drugs are of little benefit to the patient hence the need for non-pharmacological interventions. Under non-pharmacological interventions, the doctors focus on dementia rather than Alzheimers disease. These interventions are meant to deal with the emotion, cognition, and behavior of the patient and manage them.

Conclusion

The management of Alzheimers disease goes further to incorporate the family members who are required to learn as much as they can about the disease. Family members of the patient are expected to assist in activities that the patient cannot perform on their own as well as encouraging them to take life positively. In addition, caregiving treatment ought to be well managed in order to allow the caregiver time to focus on their own health needs other than spending the whole time with the patient. For instance, modifications could be made to the home environment to increase the safety of the patient thus reducing the burden on the caregiver. This could involve labeling of rooms, food, and items as well as placement of safety locks.

Reference List

Becker, R., and Giacobini, E. (1997). Alzheimer Disease- From Molecular Biology To Therapy (Advances in Alzheimer Disease Therapy). New York: Springer.

Jalbert, J., Daiello, L., and Lapane, K. (2008). Dementia of the Alzheimer Type. Epidemiological Review, 30(1), 15-34.

Wayne, M., White, M., and Smith, M. (2013). Understanding Dementia. Web.

Caregiver Burden for Adult Children Whose Parent Has Alzheimers Disease

Introduction

For many years, immediate family members and other informal caregivers have acted as the primary source of care for persons with Alzheimers disease (AD). As primary caregivers, families of patients with AD experience enormous stress because the disorder requires intensive supervision of patient behavior and support of daily living, resulting in substantial morbidity not only for the patient but also for the family caregiver (Karlawish et al., 2008; Vellone et al., 2008).

Indeed, extant caregiver literature demonstrates that family caregivers of persons with AD are often fraught with emotional, psychological, physical and financial burdens that have been linked to negative health effects (Bilotta et al., 2010; Black et al., 2010). Another stream of research reports that caring for persons with AD can be a devastating experience as it attracts social stigma and discriminatory practices (Batsch & Mittelman, 2012), and negatively affects the quality of life of patients and their caregivers (Werner et al., 2012).

The constructs of caregiver burden and social stigma have been well documented in the literature (Werner & Heinik, 2008; Wilks & Croom, 2008). Caregiver burden, which is pervasive among the caregivers of AD patients but often downplayed by health services, has been defined by Bilotta et al (2010) as &a multidimensional response to physical, psychological, social and financial stressors associated with care-giving experience (p. 481).

Stigma is described in the 2012 World Alzheimers Report as &an attribute, behavior or reputation which is socially discrediting in a particular way: it causes an individual to be mentally classified by others in an undesirable, rejected stereotype rather than in an accepted, normal one (Batsch & Mittelman, 2012 p. 7). Flowing from these definitions, it is evident that family caregivers of persons with AD and other dementias shoulder a particularly heavy burden as the type of care they provide is more physically and emotionally demanding and more time consuming, hence taking a heavier toll on work and family life (Wilks & Broom, 2008). These caregivers also run the risk of being classified by others in an undesirable, misconceived, rejected stereotype as has been illuminated in the literature (Batsch & Mittelman, 2012).

It is estimated that over 70 percent of individuals with AD receive primary care in home settings (Elliot et al., 2010), implying that they interact with their children daily. In most instances, these children serve as direct caregivers to their ailing parents without the necessary mechanisms, coping strategies and social support networks that could assist them to deal with the challenges of caregiver burden (Werner et al., 2012).

At the societal level, consecutive studies have shown that most persons with AD are stigmatized, and this stigma is extended to the immediate family members (Holle et al., 2009). Family caregivers of persons with AD are often ignored by society, prejudiced or even discriminated against due to their direct association with their ailing parents or relatives (Batsch & Mittelman, 2012). Nevertheless, no comprehensive research has attempted to evaluate how such stigmatization affects adult children of parents with AD, and if the social stigma acts as a predictor or consequent of caring for persons with AD. Caregiver burden and social stigma deserve scrutiny and examination to equip adult children of dementia parents with relevant coping skills and to also facilitate the quality provision of care to the ailing parents.

Purpose of the Study

The purpose of the proposed study is to critically explore the relationship between caregiver burden and social stigma for adult children whose parents have AD. With the prevalence of AD on the rise in the United States and Europe, the accumulated level of care provided by adult children whose parents have AD is also set to intensify. The effects of caregiver burden among this group of the population, including financial, social, emotional, and physiological effects, may assume an increasingly compounded trajectory due to rising numbers of care dependents. Findings will assist in the identification of initiatives that could be used by this group of the population to cope with caregiver burden and social stigma associated with caring for parents with AD.

Specific Aims

The proposed study intends to provide evidence-based guidance for the development of initiatives to support adult children whose parents have AD to better deal with the effects of caregiver burden, including but not limited to financial burden, physical exhaustion and sleep deprivation. The study also seeks to provide evidence-based guidelines that could be deployed to assist this group of the population deal with the social stigma originating from their association with ailing parents. These outcomes are intended to not only improve the quality of care provided by adult children of parents with AD but also to enhance the quality of life of these caregivers.

Key Research Questions

The purpose and aims of the proposed research study will be addressed by answering the following key research questions:

  1. What is the relationship between caregiver burden and social stigma for adult children whose parents have Alzheimers disease?
  2. What are the observed forms of caregiver burden affecting adult children whose parents have Alzheimers disease?
  3. What are the likely causes of stigmatization targeted at these caregivers as they provide care to parents with AD?

Significance of the Problem

Extant caregiver literature demonstrates that more than 70 percent of AD patients receive their primary care from home (Elliot et al., 2010); hence their children play a fundamental role in the provision of care (Werner et al., 2012). With the prevalence rate of AD among the elderly population set to rise in the coming years (Batsch & Mittelman, 2012), family caregivers, including adult children of the patients, are faced with the stark reality of shouldering more burden and of continued exposure to social stigmatization.

Gaps in knowledge on caregiver burden and social stigma for adult children whose parents have AD continue to contribute significantly to the proliferation of adverse physical, emotional, and psychological outcomes among this group of the population. Additionally, the effect of stigma on caregiver burden among immediate family members caring for a parent or relative with AD is yet to undergo comprehensive theoretical, conceptual and empirical testing, despite a stream of research studies in the domain of mental illness literature suggesting that caregivers perception of stigma is positively associated with the increased burden (Werner et al., 2012).

In this regard, evaluating the relationship between caregiver burden and social stigma for adult children whose parents have AD will provide strategies, interventions and policy guidelines that could be used to develop their capacity to provide a fulfilling level of care to their parents while actively minimizing instances of caregiver burden.

Review of Literature

Described for the first time over a century ago by Alois Alzheimer in his landmark lecture on the various forms of Dementia, Alzheimer disease (AD) has not only continued to cause substantial morbidity for patients and their caregivers (Bilotta et al., 2010), but it also poses one of the most important challenges for health care systems in the greying societies of  for example  the United States and Europe (Holle et al., 2009). Based on epidemiological prognoses and other hospital data, AD is the most common cause of dementia for people aged over 60 years and is consistently the most frequent but misconceived postmortem diagnosis for those entering a health institution with dementia (Black et al 2010). This section aims to review the current literature on the disease and how it relates to caregiver burden and social stigma.

Brief Statistics on AD

Latest statistics contained in a report released in 2012 by Alzheimers Disease International (ADI) show that 36 million persons were living with AD globally in 2010, and the figure is projected to rise to 66 million by 2030 and more than 100 million by 2050 (Batsch & Mittelman, 2012). Many of these people depend on immediate family members for care. In the United States, for instance, an estimated 8.9 million family caregivers assist a relative aged 50 or older with AD or related dementia (Gaugler et al., 2008), and 70 percent of these caregivers are women (Akpinar et al., 2011).

One recently concluded study found that of the estimated 4.5 million elderly Americans exhibiting progressed symptoms of the disease, more than 70 percent live at home where immediate family members and friends provide practically 75 percent of their care (Elliot et al., 2010). AD is the fifth leading cause of total morbidity in the United States and the fourth leading cause of mortality for elderly Americans (Elliot et al., 2010), qualifying it as one of the most well-researched and documented types of dementia in recent years (Batsch & Mittelman, 2012).

Effects of AD

Scholars and care practitioners agree that the devastating effects of AD not only influence the patient but also the family and other informal caregivers who assume the responsibility of providing care to the patient (Karlawish et al., 2008; Vellone et al., 2008). Emerging research has found that family caregivers are fraught with emotional, psychological, physical, and financial burdens, and are known to be at elevated risk of depression due to the devastating effects associated with the disease (Black et al., 2010).

Some of these effects include memory loss that disrupts daily life; challenges in planning or solving problems; difficulty completing familiar tasks at home, at work or leisure; confusion with time or place; trouble understanding visual images and spatial relationships; new problems with words in speaking or writing; misplacing things and losing the ability to retrace steps; decreased or poor judgment; withdrawal from work or social activities; changes in mood and personality (Alzheimers Association, 2009). These devastating effects require caregivers to shoulder a particularly heavy burden of care as patients cannot care for themselves. In most instances, the heavy burden of care coupled with a multiplicity of other peripheral factors, including the caregivers own work-life and responsibilities, precipitates caregiver burden (Black et al., 2010; Vellone et al., 2008).

Caregiver Burden

Research on caregiver burden is well documented and is attracting continued interest from academics since the number of people with AD in the United States and Europe is set to increase even more than expected, in effect putting a significant burden on healthcare systems and caregivers (Batsch & Mittelman, 2012; Black et al., 2010). Bilotta et al (2010) define caregiver burden as &a multidimensional response to physical, psychological, social and financial stressors associated with care-giving experience (p. 481).

In their influential article on the dimensional analysis of caregiver burden, Savundranayagam et al (2011) define caregiver burden as &a multidimensional construct, addressing tension and anxiety (stress burden), changes in dyadic relationships (relationship burden), and time infringements (objective burden) resulting from caregiving (p. 321). These definitions demonstrate that caregiver burden can be operationalized as a multidimensional construct made up of a multiplicity of variables with the capacity to trigger higher rates of depression and anxiety in caregivers (Elliot et al., 2010), as well as embolden financial burden and the ensuing low quality of life in this group of the population (Vellone et al., 2008).

The majority of previous research studies focusing on caregiver burden have found significant correlations between higher levels of caregiver depression and higher levels of burden and negative behavioral orientation associated with the caregiving role, particularly in a family or spousal caregivers (Batsch & Mittelman, 2012; Gaugler et al., 2008). Elliot et al (2010) report that caregivers & have been found to report lower self-rated health scores; display fewer health-promoting behaviors; and have higher morbidity and mortality rates, more sleep problems, and high numbers of illness-related symptoms (p. 30).

Flowing from these assertions, it is evident that caregivers shoulder a heavy burden of care, which may adversely affect their physical, mental, and psychological wellbeing as well as their financial independence and work-related obligations. Additionally, as suggested by Black et al (2010), the physical wellbeing of caregivers is substantially compromised as a function of care burden because the baseline health and wellbeing of caregivers contributes significantly to the prediction of depressive symptoms, anxiety and low quality of life. A stream of current research (e.g., Elliot et al., 2010; Holle et al., 2009; Wilks & Croom, 2008) demonstrates that family caregivers of persons with AD and other forms of dementia continue to record the highest depression scores and the largest increases in depression, as well as an exacerbation of physical health challenges.

Family Caregivers & Burden

It is acknowledged in the literature that immediate family members provide personal care that is integral to assisting disabled older adults to remain in their homes (Gaugler et al., 2008) and that this care is not without its costs particularly in the context and scope of AD (Akpinar et al., 2011). In their research on enhancing caregiver health, Elliot et al (2010) acknowledge that &the amount of time that primary caregivers (CGs) spend providing informal care to their loved ones with dementia ranges from 69 to 117 hours per week (p. 30).

These authors further posit that the stress and burden that accompanies caring for persons experiencing the slow progressive deterioration of AD, along with the associated intellectual impairment, can have adverse physical, mental, and psychological health effects on the family caregiver. As the disabilities and care requirements of the individual with AD increase over time due to the degenerative nature of the disease, the accumulated financial, social, emotional, and physiological effects of family caregiving also intensify (Gaugler et al., 2008).

Emerging research has found that the amount of time family caregivers spend in the caregiving role often leaves little time or resources for them to take part in gainful employment (Karlawish et al., 2008), or even attend to their responsibilities such as health-promoting practices and healthcare needs (Elliot et al., 2010). It has been well documented in the literature that immediate family members serve as the primary source of short and long-term emotional assistance and instrumental service to the AD patient (Gaugler et al., 2008), hence are exposed to a higher burden of care within the context of financial, psychological, mental and physical domains (Bilotta et al., 2010).

Although family caregivers play a fundamental function in maintaining AD patients in the community and preventing or delaying their impending institutionalization, they are nevertheless exposed to physical and psychological stressors due to the nature and scope of care required (Akpinar et al., 2011), hence are more predisposed to mental and emotional strain as well as low quality of life (Vellone et al., 2008).

Extant literature demonstrates that the physical and mental health and well-being of family caregivers, along with other functional variables such as social support and financial resources, has a direct impact on the quality of caregiving and it is a significant consideration in its own right since AD patients require emotional, physical, and fiscal commitment (Holle et al., 2009; Wilks & Croom, 2008). Indeed, as demonstrated by Vellone et al (2008), the consequence of these burdensome activities may negatively impact the physical, psychological and psychosocial dimensions of family caregiving. The consequence of these activities may also jeopardize caregiving efforts and the relationship between the family caregiver and the AD patient, leading to neglect, abuse and low quality of life for the patient as well as the caregiver (Vellone et al., 2008; Wilks & Croom, 2008).

Consequently, the prevention and reduction of the burden of caregiving should be considered a priority to family caregivers of AD patients, since an overpowering burden will not only deteriorate the physical, physiological and mental well-being of the caregiver (Gaugler et al., 2008), but will also cause an increase in the incidence of offensive and negligent behaviors from family caregivers to their relatives (Elliot et al., 2010).

Social Stigma

Stigma has been defined in the 2012 Worlds Alzheimers Report as &an attribute, behavior or reputation which is socially discrediting in a particular way: it causes an individual to be mentally classified by others in an undesirable, rejected stereotype rather than in an accepted, normal one (Batsch & Mittelman, 2012, p. 7).

These authors believe that stigma is to a large extent fuelled by the perceptions people have about the symptoms of AD, including those of considering AD as a normal component of aging, mental or psychological illness, something metaphysical associated with paranormal or spiritual beliefs, witchcraft or foul play, or as an irreparable and irremediable disease of the brain. In a related study, Werner & Heink (2008) acknowledge that stigma associated with various forms of dementia and other mental conditions consists of the perception that individuals with these dementias have objectionable characteristics, leading to a devaluation of these individuals.

Werner & Heink (2008) acknowledge that &stigma affects not only the person with the mental disorder but also those surrounding the person, including family and professionals (p. 92). When directed at the patient, stigma causes the individual to be classified by the community in an undesirable, rejected stereotype (Batsch & Mittelman, 2012), and prevents them from acknowledging symptoms and obtaining the help they require (Werner et al., 2012). This orientation substantially limits their quest for successful treatment and management of AD, and also contributes to the isolation of the patients and erosion of their self-esteem and social adjustment (Werner & Heink, 2008).

Emerging research demonstrates that immediate family members providing care to their relatives with AD are exposed to stigma under their association with their sick relatives (Werner & Heink, 2008). As observed by these authors, &stigma by association may cause fear, low self-esteem, shame, distrust, anger, inability to cope, hopelessness and increased burden for family members (p. 92). Other studies have found stigmatization and discrimination of family caregivers in social relationships through decreased social contacts with the outside world, assignment of guilt, assignment of shame and avoidance, as well as concealment of the sick relative (Vellone et al., 2008; Werner et al., 2012).

Flowing from this review, it is important to undertake a critical examination of the relationship between caregiver burden and social stigma for family members assisting persons with AD not only to inform policy and practice directions, but also to come up with alternatives that could assist them to cope with the heavy burden of care. More importantly, it is imperative to consider the plight of adult children whose parents have AD because this group of the population acts as direct primary caregivers to their elderly and frail parents (Argyle et al., 2010; Elliot et al., 2010), hence shoulder much of the burden and stigmatization by society (Werner & Heink, 2008). The next section evaluates the study design, participants and sampling, instrumentation, and how data will be analyzed.

Study Design & Variable Description

The proposed study will employ a quantitative research method to critically investigate the relationship between caregiver burden and social stigma for adult children whose parents have AD. Hopkins (2000) acknowledges that a substantial number of quantitative research studies are implicitly concerned with evaluating the correlation between variables of interest, and are either descriptive or experimental. A quantitative research design fits the demands, resources and scope of the proposed study as it is objective, time-independent and context-free in its generalizations and findings (Welford et al., 2012).

The proposed study will utilize a descriptive research design because participants will only be measured once (Jirojwong et al., 2011), and the variables of interest will include caregiver burden (independent variable) and social stigma (dependent variable). The age of participants (adult children) will be used as the controlling variable. A self-administered survey approach will be employed to collect quantitative data among the sampled participants. Extant research demonstrates that a survey approach in the form of a self-administered questionnaire is particularly effective when investigators are essentially interested in descriptive, explanatory, or exploratory evaluation of variables as is the case in the proposed study (Jirojwong et al., 2011).

Population & Sample

Potential participants for the proposed study will comprise adult children of AD patients attending a memory clinic for elderly persons and their families in four selected health and mental institutions within the region. 100 caregivers within this population will be selected using the purposive sampling technique to take part in the study. Purposive sampling is a non-probability sampling technique that samples participants based on their understanding of the topic under study (Jirojwong et al., 2011), thus the justification to use the technique in the proposed study because it promises data that is rich in context. The inclusion criteria for selection will consist of

  • being of 18 years of age or older,
  • being the primary caregiver of an elderly parent with a diagnosis of probable AD, and
  • exhibiting interest to take part in the study.

Underage providers and those extending care to AD relatives other than their parents will be automatically excluded from the study.

Protection of Human Subjects

Potential participants will be approached by the researchers, who will describe the aim of the study and ask for their consent to take part in the study. The study will not involve any deception or debriefing because its purely for academic purposes. Participants will be allowed the right to withdraw from the investigation at any given time and for any reason, though the researchers will take time to explain to them the importance of completing and submitting the questionnaire.

The right to confidentiality will also be explicitly explained to the participants, with the guarantee that no personal details will be included in the questionnaire apart from general demographic information. Participants will be assured in writing that the responses included in the questionnaire will be kept in strict confidence and will only be used to fulfill purely academic objectives. Lastly, ethical approval will be sought from the University Ethics Board and the respective administrations of the four health institutions targeted for the study.

Setting

Data will be collected from participants attending memory clinics in the four health institutions that provide health care services to patients with Dementia. In the United States and other European nations, caregivers of dementia patients are always encouraged to accompany them to the memory/treatment clinics, with the view to learning about coping strategies and how to provide quality care to patients with AD (Elliot et al., 2010). The practice and care centers across the four health institutions will form the setting for the proposed study. It is imperative to note that the four health institutions will be selected by the researchers at a later date. However, they must be close to each other to facilitate data collection exercises, and to also ensure minimal financial resources are used on transportation.

Instruments

The main instrument used for data collection will be the questionnaire. The questionnaire, which will be self-administered, will contain items of diverse layouts including multiple-choice items, asking either for a single choice or all that apply; dichotomous responses such as Yes and No; self-evaluation items, measured on the 5-point Likert-type scale and intended to measure participants attitudes and perceptions on caregiver burden and social stigma; and unstructured/open-ended items intended to elicit responses that cannot be captured by closed-ended items. In the development and piloting of the questionnaire, the investigators will rely on the identification of the conceptual domain and the review of extant literature for purposes of guaranteeing the content validity of the survey instrument (Phillips & Starwaski, 2008).

The justifications for using the questionnaire schedule are many and varied (Jirojwong et al., 2011), and include ease of application and adaptability; cost-effectiveness; and ease of undertaking comparative analysis (Phillips & Starwaski, 2008). Additionally, questionnaires allow researchers the liberty to incorporate unstructured items to enquire about new information which may be previously unknown to them or to merely explore new horizons. Lastly, not only do questionnaires have the capacity to attain a high response rate than other methods of data collection, but they are also able to guarantee participant anonymity and confidentiality because the names/physical identities of the sampled participants are of no significance to the study (Phillips & Starwaski, 2008).

Data Analysis

Data from the field will first be coded before being entered into SPSS for Windows (Statistical Package for Social Sciences) for cleaning, tabulation, and analysis. Afterward, the SPSS program will be used to run descriptive statistics (means, frequencies, standard deviations, and percentages) to characterize participants and the main variables, which include caregiver burden and social stigma. The scores will be used to test the relationship between caregiver burden and social stigma for adult children whose parents have been diagnosed with AD. Cross-tabulations will be used to draw relationships between variables.

The resultant data will further be harnessed, analyzed, and presented using multiple statistical presentations included in the SPSS program, such as pie charts, bar graphs, and line graphs. Normal text will also be used as one of the means to present findings. The analysis will focus on addressing the relationship between caregiver burden and social stigma for adult children whose parents have Alzheimers disease.

References

Akpinar, B., Kucukguciu, O., & Yener, G. (2011). Effects of gender on burden among caregivers of Alzheimers patients. Journal of Nursing Scholarship, 43(3), 248-254.

Alzheimers Association. (2009). Basics of Alzheimers disease: What it is and what you can do. Web.

Argyle, E., Downs, M., & Tasker, J. (2010). Continuing to care for people with dementia. Web.

Batsch, N.L., & Mittelman, M.S. (2012). World Alzheimer Report 2012: Overcoming the stigma of dementia. Alzheimers Disease International. Web.

Bilotta, C., Bergmaschini, L., Arienti, R., Spreafico, S., & Vergani, C. (2010). Caregiver burden as a short-term predictor of weight loss in older outpatients suffering from mild to moderate Alzheimers disease: A three months follow-up study. Aging & Mental Health, 14(4), 481-488.

Black, S.E., Gauthier, S., Dalziel, W., Keren, R., Correia, J., Hew, H., & Binder, C. (2010). Canadian Alzheimers disease caregiver survey: Baby-boomer caregivers and burden of care. International Journal of Geriatric Psychiatry, 25(8), 807-813.

Elliot, A.F., Burgio, L.D., & Decoster, J. (2010). Enhancing caregiver health: Findings from the resources for enhancing Alzheimers caregiver health II intervention. Journal of the American Geriatrics Society, 58(1), 30-37.

Gaugler, J.E., Roth, D.L., Haley, W.E., & Mittelman, M.S. (2008). Can counseling and support reduce burden and depressive symptoms in caregivers of people with Alzheimers disease during the transition to institutionalization? Results from the New York University caregiver intervention study. Journal of the American Geriatrics, 56(3), 421-428.

Holle, R., Grabel, E., Ruckdaschel, S., Wunder, S., Mehlig, H., Marx, P&Lauterberg, J. (2009). Dementia care initiative in primary practice-study protocol of a cluster randomized trial on dementia management in a general practice setting. BMC Health Services Research, 9(91), 1-11.

Hopkins, W.G. (2000). Quantitative research design. Web.

Jirojwong, S., Johnson, M., & Welch, A.J. (2011). Research methods in nursing and midwifery: Pathways to evidence-based practice. Oxford: Oxford University Press.

Karlawish, J.H.T., Casarett, D.J., James, B.D., Tenhave, T., Clark, C.M., & Asch, D.A. (2008). Why would caregivers not want to treat their relatives Alzheimers disease? Journal of the American Geriatrics Society, 51(10), 1391-1397.

Phillips, P.P., & Starwaski, C.A. (2008). Data collection: Planning for and collecting all types of Data. London: John Wiley & Sons.

Savundranayagam, M.Y., Montgomery, R.J.V., & Kostoski, K. (2011). A dimensional analysis of caregiver burden among spouses and adult children. The Gerontologist, 51(3), 321-331.

Vellone, E., Piras, G., Talucci, C., & Cohen, M.Z. (2008). Quality of life for caregivers of people with Alzheimers disease. Journal of Advanced Nursing, 61(2), 222-231.

Welford, C., Murphy, C., & Casey, D. (2012). Demystifying nursing research terminology: Part 2. Nursing Researcher, 19(2), 29-35.

Werner, P., & Heinik, J. (2008). Stigma by association and Alzheimers disease. Aging & Mental Health, 12(1), 92-99.

Werner, P., Mittelman, M.S., Goldstein, D., & Heinik, J. (2012). Family stigma and caregiver burden in Alzheimers disease. The Gerontologist, 52(1), 89-97.

Wilks, S.E., & Croom, B. (2008). Perceived stress and resilience in Alzheimers disease caregivers: Testing moderation models of social support. Aging & Mental Health, 12(3), 357-365.

Analysis of Alzheimers Disease

Introduction

Throughout the lifespan of humans, there are many changes that occur and influence physical and psychological health. Notably, people who are in their late adulthood are likely to have more medical issues because the body organs weaken with time. One of the common issues affecting senior citizens is Alzheimers disease, which impacts the brain. According to Smodic et al. (2019), new individuals develop the disorder every 25 seconds. Notably, the majority of those who are diagnosed with dementia in their mid-sixties develop mild symptoms which worsen as they grow older (Alzheimers disease, 2019). The objective of this paper is to discuss Alzheimers disease focusing on the problem, affected population, cultural, financial, legal, and ethical implications of the condition.

Problem Definition

Alzheimers disease is an irreversible and progressive neurodegenerative disorder that affects the thinking skills, memory, and other functional abilities of the patient. It was first discovered in 1906 when Dr. Alois Alzheimer noticed some changes in the brain tissues of a female patient (Alzheimers disease, 2019). Currently, in developed nations, it is among the top six causes of death (Moradifard et al., 2018). Clinically, the condition results from the accumulation of intracellular neurofibrillary tangles and extracellular and insoluble amyloid-beta plaques in the brain. In other cases, the victims nerve cells and neurons disconnect and prevent messages from being transmitted.

There are significant financial, physical, emotional, and social implications of the disorder. Lin et al. (2019) state that in the United States, the disease consumes 18 billion hours, which is equivalent to $230 billion of unpaid assistance. The family of the patient may experience significant stress when their relative start to lose memory and other key functions. Managing the disease is also costly as money is needed to purchase medications and other nursing home bills. The other challenge is that the disorder affects the elderly people who are, in most cases, retired and cannot continue to work and fund their care. Worse still, legal and ethical concerns may arise and cause disagreement within the family.

Affected Population

Alzheimers disease affects people in their early onset of late adulthood, during which the symptoms may be mild. Genetic mutation may be responsible for senior citizens developing the disease. Specifically, those individuals who have apolipoprotein E (APOE) are more likely to have Alzheimers in the future (Alzheimers disease, 2019). The implication is that people who have close relatives such as parents or siblings with Alzheimers are at a higher risk of getting the disorder later in life. However, the variations or similarity of genes does not necessarily mean that the person will develop the disorder. People who have memory problems, especially with a condition referred to as mild cognitive impairment, are also at an increased risk of developing Alzheimers. With regards to sex, both males and females can have the disease, but women are diagnosed with it more frequently (Moradifard et al., 2018). The disorder can also affect a person from any ethnic or racial group globally.

Cultural Implications

Culture can be described as a way of life of people in a particular society characterized by belief on specific ideas, rules, and shared meaning. Smodic et al. (2019) state that individuals always try to find meaning based on their belief systems. The symptoms of Alzheimers disease and the fact that it is a lifelong condition cause people to perceive the patients as negatively different. The introduction of otherness and labeling of those with the condition with words such as mad person result in stigma (Lee-Fay & Purwaningrum, 2020). Depending on the traditions, different interventions such as prayers and consulting with doctors are used for the management of the disorder.

Financial, Legal, and Ethical Implications

Managing Alzheimers is expensive, especially in the later stages when patients become functionally dependent and may need constant professional attention. A person spends a significant amount of money on medications which help to make the prognosis slow. The other implication is that caregivers such as the children of the person suffering from the disease have to take time off their duties to care for the ailing relative; such support amounts to $230 billion (Lin et al., 2019). People without an insurance plan have to spend more money to receive good medical care. Individuals can take advantage of the illness to steal possessions, or there may be confusion about the desires of the patient. One of the ethical concerns for patients with Alzheimers disease arises when the patient depends on a life support machine to survive. The dilemma that the relatives face is whether the patient would prefer to die or depend on medical machines.

Interventions

One of the interventions that are required is to promote cognitive functioning since Alzheimers diseases affect the brain and neurons. The nursing interventions should aim at enhancing the quality of life through and retaining the functional abilities of the patient. The healthcare provider can suggest strategies that caretakers can adopt to aid the senior citizens with AD compensate for their memory loss. For example, the family members can make a routine of always introducing themselves so that the patient does not feel bad for forgetting. Moreover, written reminders can also help the person to remain active for longer. Having a timetable for doing activities such as eating, taking a shower, exercising and dressing also creates order and makes it easy for the individual with Alzheimers to remember.

To improve physical health, the patient should be given a proper diet and regular exercise. Other solutions are intended to reduce the chances of injury such as providing adequate shoes according to the foot lengths and widths of subjects with AD (López-López et al., 2020, p. 286). In addition, pharmacological solutions including antidepressant medications can be effective in managing the symptoms. For safety measures, the patient should not be allowed to walk on a slippery surface or the stairs to minimize the chances of falls. These interventions require the collaboration of both the medical personnel and the family of a patient.

Available Resources

Human resource is most important for all the intervention to be implemented. Qualified healthcare professionals can help with providing factual information about Alzheimers to the public. There are also medical resources such as psychotropic medications which lower the negative side effects of Financial resources and are also required in the implementation of some of the interventions. For instance, money is needed to do more tests that will lead to improved care for the patient. Other physical assets such as offices, hospitals, and laboratories may also be required for the interventions.

Intervention Cost

The patient should have insurance cover since managing the diseases can be costly. First, money is needed for psychotropic drugs and for other treatment and professional consultation. The patient may also be placed on a special diet and an exercise program which requires more money. The budget should also include renovation and repair of the house such as having carpets to make the floor fit for the patient to walk. For patients with severe symptoms, family members may be forced to transfer them to a nursing home and cater for the expenses. Overall, the cost of implementing all the interventions may be high at the start but in the long term, it will reduce the instances and complications of Alzheimers.

Sustainability of the Interventions

To sustain the intervention, patients should have health insurance and write a will that will guide the healthcare providers and family members concerning the treatment option that is best preferred. If the cost of paying other service providers such as gym instructors for exercise is high then the caregivers can adopt alternative ways such as taking the patient for a walk to reduce the expenses. Continuous education and the creation of awareness of Alzheimers disease and its consequences are needed to aid in early planning. Research is also important to help in evaluating current intervention measures and adopting other evidence-based practices.

Conclusion

Alzheimers disease is a serious age-related disorder affecting the brain and is common among people in their late adulthood. The patients have physical and mental symptoms that need to be continually managed, which makes it cumbersome for the caregiver. Stigma against sick person and their relatives is also common in cultures where facts about dementia are not known. The intervention should focus on enhancing the quality of life through medications, proper diet, and exercise as well as ensuring that the residential area is safe. Patients should be guided to settle legal matters such as writing the will and insurance plan soon after their diagnosis.

References

Alzheimers disease fact sheet. (2019). National Institute on Aging. Web.

Lee-Fay, L., & Purwaningrum, F. (2020). Negative stereotypes, fear and social distance: A systematic review of depictions of dementia in popular culture in the context of stigma. BMC Geriatrics, 20, 1-16. Web.

Lin, P.-J., DCruz, B., Leech, A. A., Neumann, P. J., Aigbogun, M. S., Oberdhan, D., & Lavelle, T. A. (2019). Family and caregiver spillover effects in cost-utility analyses of Aalzheimers disease interventions. PharmacoEconomics, 37(4), 597-608.

López-López, D., Grela-Fariña, M., Losa-Iglesias, M., Calvo-Lobo, C., Rodríguez-Sanz, D., Palomo-López, P., & Becerro-de-Bengoa-Vallejo, R. (2018). Clinical aspects of foot health in individuals with Alzheimers disease. International Journal of Environmental Research and Public Health, 15(2), 286. Web.

Moradifard, S., Hoseinbeyki, M., Ganji, S. M., & Minuchehr, Z. (2018). Analysis of microRNA and gene expression profiles in Alzheimers disease: A meta-analysis approach. Scientific Reports (Nature Publisher Group), 8, 1-17.